Major stock indexes closed lower on Friday, after the week saw a flurry of corporate earnings reports from major tech firms, including Alphabet and Amazon. The healthcare industry also had its fair ...
Ken Fisher is the founder and executive chairman of Fisher Asset Management, a renowned investment and financial analysis ...
Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.
As the first earnings season of 2025 unfolds, investors are likely analyzing financial reports to refine their portfolio ...
We recently compiled a list of the 11 Best Stocks To Invest In For Grandchildren. In this article, we are going to take a ...
Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results